|
Originally published In Press as doi:10.1074/jbc.M603038200 on June 27, 2006
J. Biol. Chem., Vol. 281, Issue 34, 24390-24397, August 25, 2006
CCAAT/Enhancer-binding Protein Mediates Induction of Hepatic Phosphoenolpyruvate Carboxykinase by p38 Mitogen-activated Protein Kinase*
Liping Qiao ,
Ormond A. MacDougald , and
Jianhua Shao 1
From the
Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, Kentucky 40536 and the Departments of Molecular and Integrative Physiology and of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109
Excessive hepatic gluconeogenesis and glucose production are important contributors to hyperglycemia in both type 1 and type 2 diabetes. In diabetic humans and animal models, elevated levels of p38 mitogen-activated protein kinase (p38) are observed in several tissues. Our study shows that activity of p38 is significantly elevated in livers of db/db or streptozocin-induced type 1 diabetic mice. Using cultured hepatoma cells, we find that activation of p38 enhances expression of hepatic gluconeogenic gene phosphoenolpyruvate carboxykinase (PEPCK). Furthermore, our studies demonstrate that activation of p38 stimulates phosphorylation of CCAAT/enhancer-binding protein (C/EBP ) at serine 21 and increases its transactivation activity in the context of PEPCK gene transcription. Our results indicate that C/EBP mediates p38-stimulated PEPCK transcription in liver cells.
Received for publication, March 30, 2006
, and in revised form, June 5, 2006.
* This work was supported by American Diabetes Association Grants 1-06-RA-88 (to O. A. M.) and 1-04-JF-44 (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Graduate Center for Nutritional Sciences, University of Kentucky, 900 S. Limestone, Lexington, KY 40536-0200. Tel.: 859-323-4933 (ext. 81801); Fax: 859-257-3565; E-mail: JianhuaShao{at}uky.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. C. Cha, N. R. Oak, S. Kang, T.-A. Tran, S. Kobayashi, S.-H. Chiang, D. G. Tenen, and O. A. MacDougald
Phosphorylation of CCAAT/Enhancer-binding Protein {alpha} Regulates GLUT4 Expression and Glucose Transport in Adipocytes
J. Biol. Chem.,
June 27, 2008;
283(26):
18002 - 18011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Qiao, C. Zou, P. Shao, J. Schaack, P. F. Johnson, and J. Shao
Transcriptional Regulation of Fatty Acid Translocase/CD36 Expression by CCAAT/Enhancer-binding Protein {alpha}
J. Biol. Chem.,
April 4, 2008;
283(14):
8788 - 8795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Liu, Q. F. Collins, Y. Xiong, F. Moukdar, E. G. Lupo Jr., Z. Liu, and W. Cao
Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase
J. Biol. Chem.,
May 11, 2007;
282(19):
14205 - 14212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Naimi, N. Gautier, C. Chaussade, A. M. Valverde, D. Accili, and E. Van Obberghen
Nuclear Forkhead Box O1 Controls and Integrates Key Signaling Pathways in Hepatocytes
Endocrinology,
May 1, 2007;
148(5):
2424 - 2434.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|